Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
UiPath’s $1.54 Billion Initial Public Offering
Maravai LifeSciences’s $646.9 Million Secondary Offering
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
Nuvei Corporation’s $494 Million Secondary Offering
Davis Polk and Fasken advised Nuvei Corporation in the offering. Nuvei Corporation executed its $494 million secondary offering of 9,169,387 subordinate voting shares, including 969,387 shares purchased...
Adamas Pharmaceuticals’ $59 Million Stock Offering
Davis Polk advised the joint book-running managers in the offering. Adamas Pharmaceuticals, Inc. executed its $59 million follow-on offering of 14,375,000 shares of common stock, which included...